Fox Chase Cancer Center News

PHILADELPHIA (March 7, 2012) – Fox Chase Cancer Center has been selected as a candidate for two LIVESTRONG Community Impact Projects—a program created to bring proven cancer support projects to communities across the United States.  Hundreds of qualified hospitals, cancer centers, universities, and non-profits from across the United States applied to be part of four different projects—  Creative Center: Hospital Artist in Residence, LIVESTRONG at the YMCA, Advancing Joint Commission Palliative Care Certification in Cancer Centers, and Pillars4Life.

PHILADELPHIA (January 15, 2012) – Beat the winter blues by attending the 3rd Annual GIST Benefit Ball––an old Hollywood themed casino night that will help raise funds for cancer research at Fox Chase Cancer Center.  The event will take place on Saturday, February 18, from 7-10 p.m. at the Rittenhouse Hotel in Philadelphia (210 West Rittenhouse Square).  Guests attending the ball will enjoy passed hors d'oeuvres and stations, dancing, silent auctions, raffles, music, and of course casino games. 

PHILADELPHIA (January 30, 2012) – Fox Chase Cancer Center and the City of Philadelphia Mural Arts Program have teamed up to design and produce a new mural, entitled Pathways, that portrays Fox Chase’s three main areas of focus—bold science, breakthrough medicine, and personal touch.

PHILADELPHIA (January 9, 2012) – A new study has found that when parents get tested for breast cancer genes many of them share their results with their children—even with those who are very young. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study also revealed that most parents think that their children are not distressed when they learn about the test results.  

PHILADELPHIA (January 3, 2012) - A quarter-century of life-saving patient care and advanced blood cancer research is the legacy of Temple Bone Marrow Transplant (BMT) as the program celebrates the 25th anniversary of its founding this year.

PHILADELPHIA (December 28, 2011) – Targeted drugs, which block or disrupt particular molecules involved in the growth of tumors, have been shown to be effective treatments against many types of cancer. A new phase 3 clinical trial conducted by the Gynecologic Oncology Group (GOG) showed that a targeted therapy called bevacizumab (Avastin) effectively delayed the progression of advanced ovarian cancer. Patients with newly diagnosed advanced ovarian cancer now typically undergo surgery and chemotherapy, but the new research suggests an additional avenue of treatment.

PHILADELPHIA, PA (December 15, 2011) — Temple University Health System and Fox Chase Cancer Center today signed an Affiliation Agreement that moves both institutions closer to bringing Fox Chase Cancer Center into the Temple family – marking a major milestone for two celebrated Philadelphia institutions that will enhance cancer research and patient care in the region, both immediately and for years to come.

PHILADELPHIA, PA (December 12, 2011) — In January 2012, Holy Family University will begin offering a special section of its RN-to-BSN program exclusively at Fox Chase Cancer Center—an institution that conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach.  The University’s program was chosen, through a competitive process, to provide on-site courses for Fox Chase staff members who desire a Bachelor of Science in Nursing Degree.